ID   PTH2_HUMAN              Reviewed;         179 AA.
AC   Q9Y3E5; B3KUY4; Q9NTE5;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   10-MAY-2017, entry version 156.
DE   RecName: Full=Peptidyl-tRNA hydrolase 2, mitochondrial;
DE            Short=PTH 2;
DE            EC=3.1.1.29;
DE   AltName: Full=Bcl-2 inhibitor of transcription 1;
DE   Flags: Precursor;
GN   Name=PTRH2; Synonyms=BIT1, PTH2; ORFNames=CGI-147;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=10810093; DOI=10.1101/gr.10.5.703;
RA   Lai C.-H., Chou C.-Y., Ch'ang L.-Y., Liu C.-S., Lin W.-C.;
RT   "Identification of novel human genes evolutionarily conserved in
RT   Caenorhabditis elegans by comparative proteomics.";
RL   Genome Res. 10:703-713(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4-179.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   FUNCTION IN APOPTOSIS.
RX   PubMed=15006356; DOI=10.1016/S0092-8674(04)00204-1;
RA   Jan Y., Matter M., Pai J.-T., Chen Y.-L., Pilch J., Komatsu M.,
RA   Ong E., Fukuda M., Ruoslahti E.;
RT   "A mitochondrial protein, Bit1, mediates apoptosis regulated by
RT   integrins and Groucho/TLE corepressors.";
RL   Cell 116:751-762(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   INVOLVEMENT IN IMNEPD.
RX   PubMed=25574476; DOI=10.1002/acn3.149;
RA   Hu H., Matter M.L., Issa-Jahns L., Jijiwa M., Kraemer N., Musante L.,
RA   de la Vega M., Ninnemann O., Schindler D., Damatova N., Eirich K.,
RA   Sifringer M., Schroetter S., Eickholt B.J., van den Heuvel L.,
RA   Casamina C., Stoltenburg-Didinger G., Ropers H.H., Wienker T.F.,
RA   Huebner C., Kaindl A.M.;
RT   "Mutations in PTRH2 cause novel infantile-onset multisystem disease
RT   with intellectual disability, microcephaly, progressive ataxia, and
RT   muscle weakness.";
RL   Ann. Clin. Transl. Neurol. 1:1024-1035(2014).
RN   [11]
RP   INVOLVEMENT IN IMNEPD, AND VARIANT IMNEPD PRO-85.
RX   PubMed=25558065; DOI=10.1016/j.celrep.2014.12.015;
RA   Alazami A.M., Patel N., Shamseldin H.E., Anazi S., Al-Dosari M.S.,
RA   Alzahrani F., Hijazi H., Alshammari M., Aldahmesh M.A., Salih M.A.,
RA   Faqeih E., Alhashem A., Bashiri F.A., Al-Owain M., Kentab A.Y.,
RA   Sogaty S., Al Tala S., Temsah M.H., Tulbah M., Aljelaify R.F.,
RA   Alshahwan S.A., Seidahmed M.Z., Alhadid A.A., Aldhalaan H.,
RA   AlQallaf F., Kurdi W., Alfadhel M., Babay Z., Alsogheer M., Kaya N.,
RA   Al-Hassnan Z.N., Abdel-Salam G.M., Al-Sannaa N., Al Mutairi F.,
RA   El Khashab H.Y., Bohlega S., Jia X., Nguyen H.C., Hammami R., Adly N.,
RA   Mohamed J.Y., Abdulwahab F., Ibrahim N., Naim E.A., Al-Younes B.,
RA   Meyer B.F., Hashem M., Shaheen R., Xiong Y., Abouelhoda M.,
RA   Aldeeri A.A., Monies D.M., Alkuraya F.S.;
RT   "Accelerating novel candidate gene discovery in neurogenetic disorders
RT   via whole-exome sequencing of prescreened multiplex consanguineous
RT   families.";
RL   Cell Rep. 10:148-161(2015).
RN   [12]
RP   UBIQUITINATION AT LYS-47; LYS-76; LYS-81; LYS-95; LYS-106; LYS-115;
RP   LYS-171 AND LYS-177.
RX   PubMed=25621951; DOI=10.1038/ncb3097;
RA   Cunningham C.N., Baughman J.M., Phu L., Tea J.S., Yu C., Coons M.,
RA   Kirkpatrick D.S., Bingol B., Corn J.E.;
RT   "USP30 and parkin homeostatically regulate atypical ubiquitin chains
RT   on mitochondria.";
RL   Nat. Cell Biol. 17:160-169(2015).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 63-179.
RX   PubMed=14660562; DOI=10.1074/jbc.M311449200;
RA   De Pereda J.M., Waas W.F., Jan Y., Ruoslahti E., Schimmel P.,
RA   Pascual J.;
RT   "Crystal structure of a human peptidyl-tRNA hydrolase reveals a new
RT   fold and suggests basis for a bifunctional activity.";
RL   J. Biol. Chem. 279:8111-8115(2004).
CC   -!- FUNCTION: The natural substrate for this enzyme may be peptidyl-
CC       tRNAs which drop off the ribosome during protein synthesis.
CC       {ECO:0000250}.
CC   -!- FUNCTION: Promotes caspase-independent apoptosis by regulating the
CC       function of two transcriptional regulators, AES and TLE1.
CC       {ECO:0000269|PubMed:15006356}.
CC   -!- CATALYTIC ACTIVITY: N-substituted aminoacyl-tRNA + H(2)O = N-
CC       substituted amino acid + tRNA.
CC   -!- SUBUNIT: Monomer.
CC   -!- INTERACTION:
CC       Q08117:AES; NbExp=7; IntAct=EBI-1056751, EBI-717810;
CC       Q05397:PTK2; NbExp=2; IntAct=EBI-1056751, EBI-702142;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion.
CC   -!- PTM: Ubiquitinated by PRKN during mitophagy, leading to its
CC       degradation and enhancement of mitophagy. Deubiquitinated by
CC       USP30. {ECO:0000269|PubMed:25621951}.
CC   -!- DISEASE: Neurologic, endocrine, and pancreatic disease,
CC       multisystem, infantile-onset (IMNEPD) [MIM:616263]: A progressive
CC       multisystem disease characterized by a variety of neurologic,
CC       endocrine, and, in some patients, pancreatic features. Variable
CC       clinical symptoms include global developmental delay, hypotonia,
CC       hearing loss, ataxia, hyporeflexia, facial dysmorphism,
CC       hypothyroidism, and pancreatic insufficiency.
CC       {ECO:0000269|PubMed:25558065, ECO:0000269|PubMed:25574476}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the PTH2 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF151905; AAD34142.1; -; mRNA.
DR   EMBL; AK098219; BAG53596.1; -; mRNA.
DR   EMBL; CH471109; EAW94394.1; -; Genomic_DNA.
DR   EMBL; BC006807; AAH06807.1; -; mRNA.
DR   EMBL; AL137322; CAB70696.1; -; mRNA.
DR   CCDS; CCDS11618.1; -.
DR   PIR; T46479; T46479.
DR   RefSeq; NP_001015509.1; NM_001015509.2.
DR   RefSeq; NP_057161.1; NM_016077.4.
DR   RefSeq; XP_011523189.1; XM_011524887.1.
DR   UniGene; Hs.12677; -.
DR   PDB; 1Q7S; X-ray; 2.00 A; A/B=63-179.
DR   PDBsum; 1Q7S; -.
DR   ProteinModelPortal; Q9Y3E5; -.
DR   SMR; Q9Y3E5; -.
DR   BioGrid; 119659; 40.
DR   IntAct; Q9Y3E5; 5.
DR   MINT; MINT-4657346; -.
DR   STRING; 9606.ENSP00000376758; -.
DR   MoonProt; Q9Y3E5; -.
DR   iPTMnet; Q9Y3E5; -.
DR   PhosphoSitePlus; Q9Y3E5; -.
DR   SwissPalm; Q9Y3E5; -.
DR   BioMuta; PTRH2; -.
DR   DMDM; 6686183; -.
DR   EPD; Q9Y3E5; -.
DR   MaxQB; Q9Y3E5; -.
DR   PaxDb; Q9Y3E5; -.
DR   PeptideAtlas; Q9Y3E5; -.
DR   PRIDE; Q9Y3E5; -.
DR   TopDownProteomics; Q9Y3E5; -.
DR   DNASU; 51651; -.
DR   Ensembl; ENST00000393038; ENSP00000376758; ENSG00000141378.
DR   Ensembl; ENST00000470557; ENSP00000464327; ENSG00000141378.
DR   GeneID; 51651; -.
DR   KEGG; hsa:51651; -.
DR   UCSC; uc002ixt.4; human.
DR   CTD; 51651; -.
DR   DisGeNET; 51651; -.
DR   GeneCards; PTRH2; -.
DR   HGNC; HGNC:24265; PTRH2.
DR   HPA; HPA012897; -.
DR   MalaCards; PTRH2; -.
DR   MIM; 608625; gene.
DR   MIM; 616263; phenotype.
DR   neXtProt; NX_Q9Y3E5; -.
DR   OpenTargets; ENSG00000141378; -.
DR   PharmGKB; PA143485586; -.
DR   eggNOG; KOG3282; Eukaryota.
DR   eggNOG; COG1990; LUCA.
DR   GeneTree; ENSGT00390000015991; -.
DR   HOGENOM; HOG000227349; -.
DR   HOVERGEN; HBG049458; -.
DR   InParanoid; Q9Y3E5; -.
DR   KO; K04794; -.
DR   OMA; QVAHGAV; -.
DR   PhylomeDB; Q9Y3E5; -.
DR   TreeFam; TF324583; -.
DR   BRENDA; 3.1.1.29; 2681.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   SIGNOR; Q9Y3E5; -.
DR   ChiTaRS; PTRH2; human.
DR   EvolutionaryTrace; Q9Y3E5; -.
DR   GenomeRNAi; 51651; -.
DR   PRO; PR:Q9Y3E5; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000141378; -.
DR   CleanEx; HS_PTH2; -.
DR   CleanEx; HS_PTRH2; -.
DR   ExpressionAtlas; Q9Y3E5; baseline and differential.
DR   Genevisible; Q9Y3E5; HS.
DR   GO; GO:0005829; C:cytosol; IMP:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0004045; F:aminoacyl-tRNA hydrolase activity; IMP:CAFA.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:2000811; P:negative regulation of anoikis; IMP:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:2000210; P:positive regulation of anoikis; IMP:UniProtKB.
DR   Gene3D; 3.40.1490.10; -; 1.
DR   InterPro; IPR023476; Pep_tRNA_hydro_II_dom.
DR   InterPro; IPR002833; PTH2.
DR   Pfam; PF01981; PTH2; 1.
DR   SUPFAM; SSF102462; SSF102462; 1.
DR   TIGRFAMs; TIGR00283; arch_pth2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; Complete proteome; Disease mutation;
KW   Hydrolase; Isopeptide bond; Mitochondrion; Reference proteome;
KW   Transit peptide; Ubl conjugation.
FT   TRANSIT       1     62       Mitochondrion. {ECO:0000255}.
FT   CHAIN        63    179       Peptidyl-tRNA hydrolase 2, mitochondrial.
FT                                /FTId=PRO_0000029862.
FT   CROSSLNK     47     47       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:25621951}.
FT   CROSSLNK     76     76       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:25621951}.
FT   CROSSLNK     81     81       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:25621951}.
FT   CROSSLNK     95     95       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:25621951}.
FT   CROSSLNK    106    106       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:25621951}.
FT   CROSSLNK    115    115       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:25621951}.
FT   CROSSLNK    171    171       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:25621951}.
FT   CROSSLNK    177    177       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:25621951}.
FT   VARIANT      85     85       Q -> P (in IMNEPD; dbSNP:rs730882234).
FT                                {ECO:0000269|PubMed:25558065}.
FT                                /FTId=VAR_073386.
FT   STRAND       65     72       {ECO:0000244|PDB:1Q7S}.
FT   HELIX        73     75       {ECO:0000244|PDB:1Q7S}.
FT   HELIX        79    100       {ECO:0000244|PDB:1Q7S}.
FT   HELIX       102    110       {ECO:0000244|PDB:1Q7S}.
FT   STRAND      115    122       {ECO:0000244|PDB:1Q7S}.
FT   HELIX       123    135       {ECO:0000244|PDB:1Q7S}.
FT   STRAND      140    145       {ECO:0000244|PDB:1Q7S}.
FT   STRAND      147    151       {ECO:0000244|PDB:1Q7S}.
FT   STRAND      153    165       {ECO:0000244|PDB:1Q7S}.
FT   HELIX       166    173       {ECO:0000244|PDB:1Q7S}.
SQ   SEQUENCE   179 AA;  19194 MW;  11A0BA9ECF6B5E46 CRC64;
     MPSKSLVMEY LAHPSTLGLA VGVACGMCLG WSLRVCFGML PKSKTSKTHT DTESEASILG
     DSGEYKMILV VRNDLKMGKG KVAAQCSHAA VSAYKQIQRR NPEMLKQWEY CGQPKVVVKA
     PDEETLIALL AHAKMLGLTV SLIQDAGRTQ IAPGSQTVLG IGPGPADLID KVTGHLKLY
//
